These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 26844789

  • 1. Mothers, Babies, Depression, and Medications: Understanding the Complex Interplay of Illness and Treatment on Neonatal Symptoms.
    Chaudron LH.
    Am J Psychiatry; 2016 Feb 01; 173(2):101-2. PubMed ID: 26844789
    [No Abstract] [Full Text] [Related]

  • 2. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM.
    Am J Psychiatry; 2016 Feb 01; 173(2):147-57. PubMed ID: 26514656
    [Abstract] [Full Text] [Related]

  • 3. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
    Gustafsson HC, Goodman SH, Feng T, Choi J, Lee S, Newport DJ, Knight B, Pingeton B, Stowe ZN, Monk C.
    Dev Psychopathol; 2018 Aug 01; 30(3):773-785. PubMed ID: 30068426
    [Abstract] [Full Text] [Related]

  • 4. Selective serotonin reuptake inhibitors for depression in pregnancy.
    Susser LC, Sansone SA, Hermann AD.
    Am J Obstet Gynecol; 2016 Dec 01; 215(6):722-730. PubMed ID: 27430585
    [Abstract] [Full Text] [Related]

  • 5. A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.
    Stohl H, Kohm AD, Dossett E.
    J Neonatal Perinatal Med; 2016 Dec 01; 9(1):1-5. PubMed ID: 27002264
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E, Carceller AM, Agogué C, Martin BZ, St-André M, Francoeur D, Bérard A.
    Pediatrics; 2007 Jan 01; 119(1):52-9. PubMed ID: 17200271
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.
    J Clin Psychiatry; 2004 Feb 01; 65(2):230-7. PubMed ID: 15003078
    [Abstract] [Full Text] [Related]

  • 9. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
    Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM.
    Mol Psychiatry; 2008 Jan 01; 13(1):65-73. PubMed ID: 17519929
    [Abstract] [Full Text] [Related]

  • 10. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A, Ciolino JD, Pinheiro E, Rasmussen-Torvik LJ, Sit DKY, Wisner KL.
    J Clin Psychiatry; 2017 May 01; 78(5):605-611. PubMed ID: 28570796
    [Abstract] [Full Text] [Related]

  • 11. Neonatal morbidity due to maternal use of two antidepressant drugs.
    Jwa S, Wada Y, Yamamoto M, Sumida Y.
    Pediatr Int; 2018 Jan 01; 60(1):87-88. PubMed ID: 29235219
    [No Abstract] [Full Text] [Related]

  • 12. Findings from selective serotonin reuptake inhibitor-exposed neonates should be interpreted with caution.
    Norton JD, Worley LL, Lowery CL.
    Pediatrics; 2004 Dec 01; 114(6):1739-40; author reply 1740-1. PubMed ID: 15574649
    [No Abstract] [Full Text] [Related]

  • 13. Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure.
    Partridge MC, Salisbury AL, LaGasse LL.
    J Pediatr; 2016 Aug 01; 175():144-149.e1. PubMed ID: 27215778
    [Abstract] [Full Text] [Related]

  • 14. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 01; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 15. Atypical presentations of pregnancy-specific generalized anxiety disorders in women without a previous psychiatric background.
    Bar-Shai M, Gott D, Kreinin I, Marmor S.
    Psychosomatics; 2015 Nov 01; 56(3):286-91. PubMed ID: 25262048
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A tale of 2s: optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use.
    Oberlander TF, Wisner KL.
    Can J Psychiatry; 2012 Sep 01; 57(9):519-22. PubMed ID: 23073028
    [No Abstract] [Full Text] [Related]

  • 18. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 19. Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug?
    Bodnar LM, Sunder KR, Wisner KL.
    Am J Psychiatry; 2006 Jun 29; 163(6):986-91. PubMed ID: 16741197
    [No Abstract] [Full Text] [Related]

  • 20. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC.
    Psychopharmacology (Berl); 2011 Sep 29; 217(2):211-9. PubMed ID: 21499702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.